Small Molecule Drug Discovery
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
436
NCT06501196
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
Phase: Phase 1
Role: Lead Sponsor
Start: Jun 19, 2024
Completion: Jun 30, 2027
NCT06706076
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations
Phase: Phase 1/2
Start: Jan 9, 2025
Completion: Jul 31, 2029
Loading map...